Shouyao Holdings (Beijing) Co. Ltd. A (688197) - Total Liabilities
Based on the latest financial reports, Shouyao Holdings (Beijing) Co. Ltd. A (688197) has total liabilities worth CN¥114.81 Million CNY (≈ $16.80 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shouyao Holdings (Beijing) Co. Ltd. A (688197) cash flow conversion to assess how effectively this company generates cash.
Shouyao Holdings (Beijing) Co. Ltd. A - Total Liabilities Trend (2019–2024)
This chart illustrates how Shouyao Holdings (Beijing) Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check 688197 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Shouyao Holdings (Beijing) Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shouyao Holdings (Beijing) Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sun Country Airlines Holdings Inc
NASDAQ:SNCY
|
USA | $1.06 Billion |
|
Mercantile Bank Corporation
NASDAQ:MBWM
|
USA | $6.11 Billion |
|
Lahav LR Real Estate Ltd
TA:LAHAV
|
Israel | ILA1.06 Billion |
|
Cargojet Inc
TO:CJT
|
Canada | CA$1.35 Billion |
|
Neuca S.A.
WAR:NEU
|
Poland | zł4.76 Billion |
|
Inwido AB
ST:INWI
|
Sweden | Skr5.08 Billion |
|
NCR Voyix Corporation
NYSE:VYX
|
USA | $2.77 Billion |
|
STEVANATO GROUP SPA O.N.
F:87N
|
Germany | €1.06 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Shouyao Holdings (Beijing) Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Shouyao Holdings (Beijing) Co. Ltd. A worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shouyao Holdings (Beijing) Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shouyao Holdings (Beijing) Co. Ltd. A (2019–2024)
The table below shows the annual total liabilities of Shouyao Holdings (Beijing) Co. Ltd. A from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥113.21 Million ≈ $16.57 Million |
+24.20% |
| 2023-12-31 | CN¥91.16 Million ≈ $13.34 Million |
-1.70% |
| 2022-12-31 | CN¥92.73 Million ≈ $13.57 Million |
+63.62% |
| 2021-12-31 | CN¥56.67 Million ≈ $8.29 Million |
+58.70% |
| 2020-12-31 | CN¥35.71 Million ≈ $5.23 Million |
-19.44% |
| 2019-12-31 | CN¥44.33 Million ≈ $6.49 Million |
-- |
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, … Read more